Table 2 Subgroup analysis: impact of breast density, age, cancer type and microcalcifications regarding therapy modification after CEM regarding therapy modification
Grouping | Subgroup | Therapy modified after CEM | p value2 | |
|---|---|---|---|---|
Yes, n (%) | No, n (%) | |||
All patients | 10 (21) | 37 (79) | ||
Breast density group1 | A or B | 8 (26) | 23 (74) | |
C or D | 2 (12) | 14 (88) | 0.457 | |
Age group3 | Below 56 | 4 (27) | 11 (73) | |
56 and above | 6 (19) | 26 (81) | 0.704 | |
Cancer type (index) | Invasive ductal cancer | 5 (19) | 21 (81) | |
Invasive lobular cancer | 2 (25) | 6 (75) | ||
Other invasive cancer | 0 | 3 (100) | ||
DCIS | 1 (13) | 7 (88) | 1.0000 | |
Microcalcifications | No | 5 (17) | 24 (83) | |
Yes | 4 (25) | 12 (75) | 0.6998 | |